Lung Cancer Outsmarts KRAS Drugs Through Two Distinct Escape Routes
MIT researchers have found that lung adenocarcinomas can evade KRAS inhibitors either by amplifying the KRAS gene or by transforming ...
MIT researchers have found that lung adenocarcinomas can evade KRAS inhibitors either by amplifying the KRAS gene or by transforming ...
A new mouse study shows that lung adenocarcinomas can evade KRAS inhibitors by reprogramming their cellular identity through transcription factors ...
Mice lacking the HEAT repeat protein MROH1 develop mild hypothyroidism and thyroid remodelling, linking a conserved lysosomal scission factor to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine